Boston Scientific Corp (BSX) · Sep 23, 2026 · Exec change

Boston Scientific loses MedSurg/APAC chief as key growth businesses enter transition

Executive retirement — Retirement effective January 1, 2027; advisor through February 26, 2027

Arthur Butcher will retire from Boston Scientific’s MedSurg and Asia Pacific leadership role, leaving an important succession question despite an orderly handoff.

Boston Scientific is expanding its core medtech businesses, with MedSurg delivering 5.4% organic growth and Asia Pacific growing 11.2% in the second quarter of 2026. This changes leadership at an important growth intersection. Arthur Butcher oversees MedSurg—including Endoscopy, Urology and Neuromodulation—as well as Asia Pacific, giving the retirement broader operating scope than a routine executive reshuffle. The filing says, "Mr. Butcher has decided to retire from his role as Executive Vice President and Group President, MedSurg and Asia Pacific effective as of January 1, 2027."

The transition is orderly, but the successor question is unresolved. Butcher is expected to stay on as a senior advisor through February 26, 2027, which reduces the immediate handoff risk. 〔0〕 However, Boston Scientific names no replacement or interim leader in this filing, so execution continuity across a growing portfolio remains the key issue.

The economics are routine rather than a new strategic burden. The company expects retirement payments and benefits to follow existing executive retirement, bonus and equity arrangements, while the advisor role pays his current $780,000 annual base salary on a prorated basis.

Bottom line: This is a planned, managed departure rather than an operating setback, but it creates a real succession gap across two strategically important businesses. The next leadership appointment will determine whether the event stays administrative or becomes more consequential for execution.} live? endlaka?#+#+#+#+? Wait. JSON valid? I accidentally included weird? Need final only object. Ensure no extra. Also

What to watch next

Successor announcement for MedSurg and Asia Pacific

Original filing on SEC EDGAR

More Boston Scientific Corp news

Boston Scientific loses MedSurg/APAC chief as key growth businesses enter transition | BSX Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.